41100_2019_221_MOESM2_ESM.docx (22.9 kB)
Additional file 2: of Long-term safety and effectiveness of a continuous erythropoietin receptor activator (CERA) in patients with renal anemia: a prospective, observational, multicenter study
journal contribution
posted on 2019-06-06, 05:00 authored by Hidehiro Tabata, Hiroyuki Kanno, Ayako Murayama, Tadashi Ishii, Ryosuke Harada, Yukio UdagawaTSAT and ferritin levels, by disease stage and prior treatment. These tables provide baseline, week 24 and 52 TSAT and ferritin levels according to disease stage and history of ESA administration. (DOCX 23 kb)